BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 37482587)

  • 21. Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis.
    Sharma S; Agnihotri N; Kumar S
    Biochem Pharmacol; 2022 Apr; 198():114943. PubMed ID: 35131295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamine Metabolism in Cancer.
    Li T; Le A
    Adv Exp Med Biol; 2018; 1063():13-32. PubMed ID: 29946773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer.
    Ortiz-Pedraza Y; Muñoz-Bello JO; Olmedo-Nieva L; Contreras-Paredes A; Martínez-Ramírez I; Langley E; Lizano M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flux analysis and metabolomics for systematic metabolic engineering of microorganisms.
    Toya Y; Shimizu H
    Biotechnol Adv; 2013 Nov; 31(6):818-26. PubMed ID: 23680193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A second Warburg-like effect in cancer metabolism: The metabolic shift of glutamine-derived nitrogen: A shift in glutamine-derived nitrogen metabolism from glutaminolysis to de novo nucleotide biosynthesis contributes to malignant evolution of cancer.
    Kodama M; Nakayama KI
    Bioessays; 2020 Dec; 42(12):e2000169. PubMed ID: 33165972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted cancer therapeutics: biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors.
    Dang NH; Singla AK; Mackay EM; Jirik FR; Weljie AM
    Curr Pharm Des; 2014; 20(15):2637-47. PubMed ID: 23859615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in cancer metabolism: a technological perspective.
    Kang YP; Ward NP; DeNicola GM
    Exp Mol Med; 2018 Apr; 50(4):1-16. PubMed ID: 29657324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum metabolomics of Bama miniature pigs bitten by Bungarus multicinctus.
    Huang Z; Zhang M; He D; Song P; Mo C; Cheng X; Song T; Li Y; Zhang X; Liao M
    Toxicol Lett; 2021 Oct; 350():225-239. PubMed ID: 34343594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caveolin-1 in the regulation of cell metabolism: a cancer perspective.
    Nwosu ZC; Ebert MP; Dooley S; Meyer C
    Mol Cancer; 2016 Nov; 15(1):71. PubMed ID: 27852311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis.
    Barger JF; Plas DR
    Endocr Relat Cancer; 2010 Dec; 17(4):R287-304. PubMed ID: 20699334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational Strategies for Biological Interpretation of Metabolomics Data.
    Xia J
    Adv Exp Med Biol; 2017; 965():191-206. PubMed ID: 28132181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations.
    El Ansari R; McIntyre A; Craze ML; Ellis IO; Rakha EA; Green AR
    Histopathology; 2018 Jan; 72(2):183-190. PubMed ID: 28771772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics-on-a-chip and metabolic flux analysis for label-free modeling of the internal metabolism of HepG2/C3A cells.
    Ouattara DA; Prot JM; Bunescu A; Dumas ME; Elena-Herrmann B; Leclerc E; Brochot C
    Mol Biosyst; 2012 Jul; 8(7):1908-20. PubMed ID: 22618574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the potential link between antidepressant effect of Xiaoyao San and its pharmacological activity of hepatoprotection based on multi-platform metabolomics.
    Chen C; Yin Q; Tian J; Gao X; Qin X; Du G; Zhou Y
    J Ethnopharmacol; 2020 Mar; 249():112432. PubMed ID: 31790818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
    Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
    Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.
    Daye D; Wellen KE
    Semin Cell Dev Biol; 2012 Jun; 23(4):362-9. PubMed ID: 22349059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathway Analysis for Targeted and Untargeted Metabolomics.
    Karnovsky A; Li S
    Methods Mol Biol; 2020; 2104():387-400. PubMed ID: 31953827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconstruction and flux analysis of coupling between metabolic pathways of astrocytes and neurons: application to cerebral hypoxia.
    Cakir T; Alsan S; Saybaşili H; Akin A; Ulgen KO
    Theor Biol Med Model; 2007 Dec; 4():48. PubMed ID: 18070347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical role of glutamine metabolism in cardiomyocytes under oxidative stress.
    Watanabe K; Nagao M; Toh R; Irino Y; Shinohara M; Iino T; Yoshikawa S; Tanaka H; Satomi-Kobayashi S; Ishida T; Hirata KI
    Biochem Biophys Res Commun; 2021 Jan; 534():687-693. PubMed ID: 33213841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysis.
    Halama A; Kulinski M; Dib SS; Zaghlool SB; Siveen KS; Iskandarani A; Zierer J; Prabhu KS; Satheesh NJ; Bhagwat AM; Uddin S; Kastenmüller G; Elemento O; Gross SS; Suhre K
    Cancer Lett; 2018 Aug; 430():133-147. PubMed ID: 29777783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.